From: The INIS Study. International Neonatal Immunotherapy Study: non-specific intravenous immunoglobulin therapy for suspected or proven neonatal sepsis: an international, placebo controlled, multicentre randomised trial
Number with positive cultures
Mortality (all causes)
Number with negative cultures
204/3,963 (5%)
16/204 (8%)
3,759/3,963 (95%)
95/3,759 (2.5%)